Fidelity International’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $122M | Buy |
875,527
+209,835
| +32% | +$29.4M | 0.09% | 214 |
|
|
2025
Q4 | $81.7M | Sell |
665,692
-49,574
| -7% | -$6.02M | 0.06% | 261 |
|
|
2025
Q3 | $79.4M | Buy |
715,266
+199,668
| +39% | +$22.7M | 0.06% | 263 |
|
|
2025
Q2 | $57.2M | Buy |
515,598
+151,030
| +41% | +$16.1M | 0.05% | 318 |
|
|
2025
Q1 | $40.8M | Buy |
364,568
+352,101
| +2,824% | +$36.3M | 0.04% | 342 |
|
|
2024
Q4 | $1.15M | Sell |
12,467
-28,386
| -69% | -$2.56M | ﹤0.01% | 716 |
|
|
2024
Q3 | $3.43M | Buy |
40,853
+1,821
| +5% | +$139K | ﹤0.01% | 659 |
|
|
2024
Q2 | $2.68M | Buy |
39,032
+34,814
| +825% | +$2.32M | ﹤0.01% | 668 |
|
|
2024
Q1 | $309K | Buy |
+4,218
| New | +$324K | ﹤0.01% | 783 |
|
|
2023
Q3 | – | Sell |
-86,676
| Closed | -$6.68M | – | 812 |
|
|
2023
Q2 | $6.68M | Sell |
86,676
-46,735
| -35% | -$3.73M | 0.01% | 534 |
|
|
2023
Q1 | $11.1M | Sell |
133,411
-41,340
| -24% | -$3.42M | 0.01% | 475 |
|
|
2022
Q4 | $15M | Buy |
174,751
+18,185
| +12% | +$1.44M | 0.02% | 435 |
|
|
2022
Q3 | $9.66M | Buy |
156,566
+66,224
| +73% | +$4.18M | 0.01% | 497 |
|
|
2022
Q2 | $5.58M | Buy |
90,342
+19,120
| +27% | +$1.18M | 0.01% | 577 |
|
|
2022
Q1 | $4.23M | Sell |
71,222
-309,734
| -81% | -$19.8M | ﹤0.01% | 620 |
|
|
2021
Q4 | $27.7M | Sell |
380,956
-137,158
| -26% | -$9.45M | 0.03% | 399 |
|
|
2021
Q3 | $36.2M | Sell |
518,114
-42,533
| -8% | -$2.99M | 0.04% | 350 |
|
|
2021
Q2 | $38.6M | Buy |
560,647
+15,837
| +3% | +$1.06M | 0.04% | 350 |
|
|
2021
Q1 | $35.2M | Buy |
544,810
+544,522
| +189,070% | +$35.1M | 0.04% | 340 |
|
|
2020
Q4 | $17K | Sell |
288
-387
| -57% | -$23.4K | ﹤0.01% | 796 |
|
|
2020
Q3 | $43K | Sell |
675
-394,661
| -100% | -$27.4M | ﹤0.01% | 700 |
|
|
2020
Q2 | $30.4M | Buy |
395,336
+394,575
| +51,850% | +$30.2M | 0.04% | 332 |
|
|
2020
Q1 | $57K | Sell |
761
-249,621
| -100% | -$17.2M | ﹤0.01% | 662 |
|
|
2019
Q4 | $16.3M | Sell |
250,382
-119,999
| -32% | -$7.81M | 0.02% | 433 |
|
|
2019
Q3 | $23.5M | Sell |
370,381
-1,736,191
| -82% | -$113M | 0.04% | 352 |
|
|
2019
Q2 | $142M | Buy |
2,106,572
+259,465
| +14% | +$17.1M | 0.21% | 124 |
|
|
2019
Q1 | $120M | Sell |
1,847,107
-1,156,062
| -38% | -$76.8M | 0.19% | 141 |
|
|
2018
Q4 | $188M | Sell |
3,003,169
-164,356
| -5% | -$11.5M | 0.33% | 81 |
|
|
2018
Q3 | $245M | Buy |
3,167,525
+331,219
| +12% | +$25M | 0.36% | 69 |
|
|
2018
Q2 | $201M | Buy |
2,836,306
+659,695
| +30% | +$46.6M | 0.3% | 90 |
|
|
2018
Q1 | $164M | Buy |
2,176,611
+84,170
| +4% | +$6.69M | 0.45% | 59 |
|
|
2017
Q4 | $150M | Buy |
2,092,441
+40,924
| +2% | +$3.11M | 0.42% | 67 |
|
|
2017
Q3 | $166M | Buy |
2,051,517
+577,397
| +39% | +$44.2M | 0.48% | 55 |
|
|
2017
Q2 | $104M | Buy |
1,474,120
+1,980
| +0.1% | +$132K | 0.3% | 96 |
|
|
2017
Q1 | $100M | Buy |
1,472,140
+86,900
| +6% | +$6.11M | 0.28% | 96 |
|
|
2016
Q4 | $99.2M | Buy |
+1,385,240
| New | +$103M | 0.29% | 94 |
|
|
2016
Q3 | – | Sell |
-276,000
| Closed | -$23M | – | 527 |
|
|
2016
Q2 | $23M | Sell |
276,000
-46,229
| -14% | -$4.1M | 0.07% | 224 |
|
|
2016
Q1 | $29.6M | Sell |
322,229
-70,829
| -18% | -$6.39M | 0.09% | 202 |
|
|
2015
Q4 | $39.8M | Sell |
393,058
-37,427
| -9% | -$3.89M | 0.12% | 179 |
|
|
2015
Q3 | $42.3M | Sell |
430,485
-660,578
| -61% | -$73.4M | 0.15% | 159 |
|
|
2015
Q2 | $128M | Sell |
1,091,063
-393,462
| -27% | -$43M | 0.41% | 71 |
|
|
2015
Q1 | $146M | Sell |
1,484,525
-1,386,342
| -48% | -$141M | 0.47% | 65 |
|
|
2014
Q4 | $271M | Buy |
2,870,867
+409,472
| +17% | +$42.3M | 0.93% | 23 |
|
|
2014
Q3 | $262M | Sell |
2,461,395
-1,374,775
| -36% | -$135M | 1% | 21 |
|
|
2014
Q2 | $318M | Sell |
3,836,170
-829,756
| -18% | -$64.6M | 1.19% | 17 |
|
|
2014
Q1 | $331M | Buy |
4,665,926
+1,716,320
| +58% | +$135M | 1.2% | 13 |
|
|
2013
Q4 | $222M | Sell |
2,949,606
-25,349
| -0.9% | -$1.77M | 0.89% | 21 |
|
|
2013
Q3 | $187M | Sell |
2,974,955
-68,151
| -2% | -$4.07M | 0.89% | 23 |
|
|
2013
Q2 | $156M | Buy |
+3,043,106
| New | +$159M | 0.88% | 22 |
|
Other funds holding GILD
VCM
VPM
Fidelity International's GILD Position: Q1 2026 in Review
Fidelity International increased its Gilead Sciences (GILD) stake by 32% in Q1 2026, buying an estimated $29.4M and bringing the position to 875,527 shares worth $122M. The position accounts for 0.09% of the portfolio, ranked #214.
Fidelity International first reported a position in GILD in Q2 2013 and has held it in 49 quarters since. The position peaked at $331M in Q1 2014. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Fidelity International held 875,527 shares of Gilead Sciences worth $122M as of Q1 2026.
- Fidelity International bought 209,835 Gilead Sciences shares in Q1 2026, an estimated $29.4M.
- Gilead Sciences made up 0.09% of Fidelity International's portfolio in Q1 2026, its #214 holding.
- Fidelity International first reported a position in Gilead Sciences in Q2 2013 and has held it in 49 quarters since.
- Fidelity International's Gilead Sciences position peaked at $331M in Q1 2014.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Fidelity International's 13F filing for Q1 2026, filed 15 May 2026.